← Back to Search

Muscle Assessment Score for Liver Transplant Outcomes

N/A
Recruiting
Led By Elizabet Carey, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult
All patients with end-stage liver disease undergoing evaluation for liver transplantation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is looking at how well a muscle assessment score can predict adverse outcomes in people who need a liver transplant.

Who is the study for?
This trial is for adults with end-stage liver disease who are being evaluated for a liver transplant and can safely undergo an MRI. It's not suitable for those who have conditions that make MRI scans unsafe for them.Check my eligibility
What is being tested?
The study is looking at how muscle composition, measured by a special score from MRI images called MAsS, might predict complications or outcomes in people waiting for liver transplants.See study design
What are the potential side effects?
Since this study uses MRIs to assess muscle composition and doesn't involve medication or invasive procedures, there aren't direct side effects related to the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am being evaluated for a liver transplant due to end-stage liver disease.
Select...
I need an MRI as part of my evaluation for a transplant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse outcomes
MAsS changes while waiting for liver transplant
Muscle assessment score (MAsS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Define MAsS cut-point at transplant evaluation to identify those with high risk for adverse outcomesExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,752 Total Patients Enrolled
Amra Medical ABIndustry Sponsor
2 Previous Clinical Trials
161 Total Patients Enrolled
Elizabet Carey, MDPrincipal InvestigatorMayo Cinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are participating in this research investigation?

"That is correct. According to clinicaltrials.gov, this trial was initially published on November 2nd 2022 and has recently been updated. It is currently seeking 100 participants amongst a single medical centre."

Answered by AI

Are applications currently being accepted for this research trial?

"According to information on clinicaltrials.gov, this trial is currently enlisting participants. The listing was initially established on November 2nd 2022 and recently modified on the 8th of that same month."

Answered by AI
Recent research and studies
~11 spots leftby Jul 2024